A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Information from the National Library of Medicine NIH NLM ABRV BLK 4

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05394259

Contacts

Locations

Layout table for location information
United States, Texas
MD Anderson Cancer Center**RECRUITING NOW**
Houston, Texas, United States, 77030
Contact: Yang Lu, MD, PHD    713-792-5768    ylu10@mdanderson.org   
Principal Investigator: Yang Lu, MD, PHD         

Sponsors and Collaborators

M.D. Anderson Cancer Center

Lantheus Medical Imaging

Investigators

Layout table for investigator information
Principal Investigator:Yang Lu, MD, PHDM.D. Anderson Cancer Center

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 4, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments